Senescence in Health and Disease
By Shenghui He, N. Sharpless. Cell, 2017
1,558 citations recorded by the source corpus.
Many cellular stresses activate senescence, a persistent hyporeplicative state characterized in part by expression of the p16INK4a cell cycle inhibitor. Senescent cell production occurs throughout life and plays beneficial roles in a variety of physiological and pathological processes including embryogenesis, wound healing, host immunity and tumor suppression. Meanwhile, the steady accumulation of senescent cells with age also has adverse consequences. These non-proliferating cells occupy key cellular niches and elaborate pro-inflammatory cytokines, contributing to aging-related diseases and morbidity. This model suggests that the abundance of senescent cells in vivo predicts ‘molecular’, as opposed to chronologic, age, and that senescent cell clearance may mitigate aging-associated pathology.
Subfields: Aging, Physiology
View Paper: https://www.semanticscholar.org/paper/ee0bc18e1eb90ee8739400e6eacea15d5086f583
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Aging
- D. Klionsky
- Beth Levine
- Guido Kroemer
- Michael O. Hengartner
- C. Hetz
- D. Rubinsztein
- Navdeep S. Chandel
- D. Hanahan
In Physiology
- Guido Kroemer
- L. Galluzzi
- Beth Levine
- Douglas R. Green
- M. Jäättelä
- P. Boya
- D. Rubinsztein
- Eric H. Baehrecke
Citations in the corpus
- Cellular Senescence: Defining a Path Forward. (2019, neutral): “These diseases include neurodegenerative disorders, glaucoma, cataract, atherosclerosis and cardiovascular disease, diabetes, osteoarthritis, pulmonary, and renal and liver fibrosis (Childs et al., 2015; He and Sharpless, 2017; Mun˜oz-Espı´n and Serrano, 2014) (Table S2).”
- Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021, background): “However, expression of p21WAF1/CIP1 does not persist in senescent cells as it is mainly required for induction of senescence (Stein et al., 1999; Sharpless and Sherr, 2015; He and Sharpless, 2017; Song et al., 2020).”
- Cellular Senescence: Aging, Cancer, and Injury. (2019, background): “It is, therefore, possible that senescence plays a dual role during atherosclerosis: on one side, proliferative arrest of monocytes and macrophages limits plaque growth, but on the other side, SASP factors secreted from these cells can also induce disease progression (151).”
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018, background): “Mounting evidence, however, indicates that senescent cells accumulate during organismal aging due to their increased generation coupled to inefficient clearance [935, 941, 960, 961].”
- Hallmarks of Cancer: New Dimensions. (2022, background): “Indeed, there are well-established examples of the protective benefits of senescence in limiting malignant progression (118, 119).”